Botanical species · safety record

Rhodiola crenulata

The EFSA Compendium of Botanicals holds 6 constituent measurements for Rhodiola crenulata. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Rhodiola crenulata (Hook. f. & Thomson) H. Ohba

6Constituent measurements

0Safety records

4Cited sources

78Licensed products (Canada)

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 78 licensed products naming Rhodiola crenulata as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Extract types on licence

Dry
Extract Type TBA

Source material stated

Dried root(s)
Herb
New material
Rhizome
Rhizome(s)
Root

What the records describe

Constituents measured

Plant parts

Preparations

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

Substance	Plant part	Preparation	Concentration	Analytical method	Source
Gallic acid	Roots and other underground parts	Solvent extraction	≥ 0.72 Milligram/gram	HPLC with standard detection methods	Resolve DOI
Gallic acid	Roots and other underground parts	Solvent extraction	≤ 6.88 Milligram/gram	HPLC with standard detection methods	Resolve DOI
Gallic acid	Unspecified	Solvent extraction	—	High Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)	Resolve DOI
Lignans	Roots and other underground parts	Solvent extraction	—	HPLC-DAD	Resolve DOI
Neolignans	Roots and other underground parts	Solvent extraction	—	HPLC-DAD	Resolve DOI
Coumarins	Roots and other underground parts	Solvent extraction	—	Nuclear Magnetic Resonance (NMR)	No resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

Yang, Ya-nan., Liu, Zhao-zhen., Feng, Zi-ming., Jiang, Jian-shuang., Zhang, Pei-cheng. Lignans from the Root of Rhodiola crenulata. JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, 2012, vol. 60, no. 4, p. 964-972. DOI
DU, M., XIE, JM., XIE, JM. STUDIES ON THE CHEMICAL-CONSTITUENTS OF RHODIOLA-CRENULATA. ACTA CHIMICA SINICA, 1994, vol. 52, no. 9, p. 927-931.
Li, Tao., Zhang, Hao. Identification and comparative determination of rhodionin in traditional Tibetan medicinal plants of fourteen Rhodiola species by high-performance liquid chromatography-photodiode array detection and electrospray ionization-mass spectrometry. CHEMICAL & PHARMACEUTICAL BULLETIN, 2008, vol. 56, no. 6, p. 807-814. DOI
Liu, Q., Du, S.-Y., Duojie, R.-Q., Ynima, C.-R., Dun, Z., Ga, W. HPLC method for simultaneous quantitative determination of six active ingredients in Rhodiola crenulata from different origins of Qinghai-Tibet Plateau. Chinese Traditional and Herbal Drugs, 2015, vol. 46, no. 2, p. 276-279. DOI

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue

Independent literature